Invention Grant
- Patent Title: Use of CGRP antagonist compounds for treatment of psoriasis
-
Application No.: US15355723Application Date: 2016-11-18
-
Publication No.: US10668132B2Publication Date: 2020-06-02
- Inventor: Birkir Sveinsson
- Applicant: NEPSONE EHF
- Applicant Address: IS Reykjavik
- Assignee: NEPSONE EHF
- Current Assignee: NEPSONE EHF
- Current Assignee Address: IS Reykjavik
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K38/22
- IPC: A61K38/22 ; A61K47/44 ; A61K9/107 ; A61K31/517 ; G01N33/74 ; G01N33/50 ; A61P17/06
Abstract:
A method for treating, remedying, or preventing psoriasis by administering a therapeutically effective dose of at least one CGRP antagonist compound in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing psoriasis by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one CGRP antagonist compound in a pharmaceutically acceptable formulation.
Public/Granted literature
- US20170065681A1 USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS Public/Granted day:2017-03-09
Information query
IPC分类:
